ImaginAb Competitors and Similar CompaniesClear all
ImaginAb's competitors and similar companies include Dr Lal PathLabs, Mesoblast, ImmusanT and Artax Biopharma.
 ImaginAb ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins. |  Dr Lal PathLabs Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests. |  Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. |  ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. |  Artax Biopharma Artax Biopharma is a biotechnology company that specializes in transforming autoimmune disease treatment. | |
Founding Date | Founding Date 2007 | Founding Date 1949 | Founding Date 2004 | Founding Date 2010 | Founding Date 2013 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Inglewood, US HQ Bracknell, GB | Locations Gurugram, IN HQ | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Cambridge, US HQ | Locations Cambridge, US HQ |
Employees | Employees 195% decrease | Employees 4,099 | Employees 73 | Employees 2 | Employees 14 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹27.6b (FY, 2026) | Revenue (est.) $17.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ₹5.3b (FY, 2026) | Cost of goods $1.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ₹23.3b (FY, 2026) | Gross profit $16.1m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ₹5.1b (FY, 2026) | Net income ($102.1m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 8m (over 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 26m (about 4 years ago) |
Total funding raised | Total funding raised $ 46.8m | Total funding raised N/A | Total funding raised $ 56.2m | Total funding raised $ 72.8m | Total funding raised $ 28m |
For sources of this data, please see the company profile
View Company Profiles
Dr Lal PathLabs
HQ
Gurugram, IN
Employees
4,099
Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests.
View companyMesoblast
HQ
Melbourne, AU
Employees
73
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View companyImmusanT
HQ
Cambridge, US
Employees
2
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View companyArtax Biopharma
HQ
Cambridge, US
Employees
14
Artax Biopharma is a biotechnology company that specializes in transforming autoimmune disease treatment.
View company